Yüklüyor......
Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis
Cystic fibrosis (CF) is a life-limiting, multisystem disease characterized by thick viscous secretions leading to recurrent lung infections, bronchiectasis, and progressive deterioration in lung function. CF is caused by loss or dysfunction of the CF transmembrane conductance regulator (CFTR) protei...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3770629/ https://ncbi.nlm.nih.gov/pubmed/24039402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S30345 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|